Aslan Fred sold ARTV
September 8, 2026 · Form 4 insider transaction
Aslan Fred sold 23,429 shares of Artiva Biotherapeutics, Inc. at $10.92 per share, a transaction worth $255.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
23,429
Price
$10.92
Total value
$255.7K
InsiderAslan Fred
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 8, 2026
Filing dateSeptember 9, 2026
Shares owned after1,449,765
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 13, 2026.; The weighted average sale price for the transaction reported was $10.9158, and the range of prices were between $10.72 and $11.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.